GEN Exclusives

More »

GEN News Highlights

Back to Item »

Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership

Merck & Co. will partner with Eisai to codevelop its marketed cancer treatment Lenvima ®  (lenvatinib mesylate) for additional ...

Forward this item to a colleague:


(Separate multiple addresses by commas)